MTEM News and Press, Molecular Templates Inc. From 03/31/23

2023-03-31 03:46:54 ET Molecular Templates press release ( NASDAQ: MTEM ): Q4 GAAP EPS of -$0.39 misses by $0.09 . Revenue of $2.6M (-85.6% Y/Y) misses by $6.21M . As of December 31, 2022, MTEM’s cash and investments totaled $61.0M. For further det...

AUSTIN, Texas, March 30, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, enginee...

2023-03-10 09:21:18 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Allbirds (NASDAQ: BIRD ) stock is falling hard on Friday following the release of its earnings report for the fourth quarter of 2022. The bad news for BIRD stock starts ...

2023-03-10 08:53:54 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips SVB Financial (NASDAQ: SIVB ) stock continued to fall on Friday after the company revealed plans for a public offering to raise funds . News of that offering sent shares...

2023-03-10 08:39:18 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Barnes & Noble Education (NYSE: BNED ) stock is climbing higher on Friday following the release of its earnings report for the fiscal third quarter of 2023 . That ea...

2023-03-10 08:01:57 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Molecular Templates (NASDAQ: MTEM ) stock is rocketing higher on Friday after the company got approval from the Food and Drug Administration (FDA) . That FDA approval ha...

2023-03-10 07:28:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting the final day of the week with a breakdown of the biggest pre-market stock movers on Friday! Moving stocks this morning is a U.S. Food and Drug Administration (FDA) up...

2023-03-09 10:44:51 ET Molecular Templates ( NASDAQ: MTEM ) added ~9% in the morning hours Thursday after announcing that the FDA has greenlighted its Investigational New Drug Application for MT-8421, an anti-tumor candidate targeted at CTLA-4-expressing Regulatory T (Treg...

AUSTIN, Texas, March 09, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, enginee...

AUSTIN, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, enginee...